Monday, February 18, 2019
Home »
» Medical News Today: What to expect from Lupron treatment
Medical News Today: What to expect from Lupron treatment
Lupron (leuprolide acetate) is a type of hormone therapy for people with prostate cancer. Lupron is an injection drug, and doctors often prescribe it in combination with radiation therapy or surgery. As it lowers a person’s testosterone levels, Lupron can cause a range of side effects. Learn more here.
Related Posts:
Kentucky tobacco-free advocates win Campaign for Tobacco-Free Kids' national Group Youth Advocates of the Year award The University of Kentucky #iCANendthetrend Youth Advisory Board was named the Campaign for Tobacco-Free Kids' Group Youth Advocates of the Year. Front row, from left areSaumya Sikhwal, Jasmin Hernandez, Sarah… Read More
Provisional data shows overdose deaths dropped in Kentucky much more than nationwide, but the number of ODs is still high Centers for Disease Control and Prevention graph By Melissa Patrick Kentucky Health News The Centers for Disease Control and Prevention's latest provisional overdose-death data say drug-overdose deaths in Kent… Read More
Study: E-cig use raises risk of early development of asthma 252% Studies show vaping may contribute to the development of asthma. (Image from Very Well Health) Kentucky Health News There is a significant link between vaping and asthma in adults, according to a new stud… Read More
Kentucky treatment and recovery leaders honored with awardsBy Melissa Patrick Kentucky Health News Six Kentuckians were honored with 2024 Champions of Recovery Awards at the Kentucky Chamber of Commerce's ninth annual Kentucky Workforce Summit held in Lexington on May 14. … Read More
Tips to prevent drowning, No. 1 cause of unintentional injury-related death among children under 5; swim lessons reduce riskBy Melissa Patrick Kentucky Health News As summer approaches and people begin to head to pools, lakes, ponds and streams, it's important to remember that drownings can happen to anyone in a matter of seconds – and that they … Read More
0 comments:
Post a Comment